Fda Approved Drug
- All
- News
- Videos
-
Higher-Dose Wegovy Gets US Nod, Trials Show Over 20% Average Weight Loss, Says Drugmaker
Novo Nordisk said it plans to launch the new formulation, (semaglutide 7.2 mg), in the United States in April 2026.
-
Woman With Stage-3 Colorectal Cancer Recovers In Only 4 Months, Thanks To This New Therapy
Mrinali Dhembla, 27, diagnosed with stage-3 colorectal cancer and Lynch syndrome, recovers rapidly after receiving a dual immunotherapy regimen.
-
Hyderabad-Based Pharmaceutical Gets US Nod For Generic ADHD Drug: Why This Matters And What It Means
ADHD is a neurodevelopmental condition that affects both children and adults. It is characterised by symptoms such as difficulty concentrating, impulsive behaviour and hyperactivity.
-
First Oral Pill For Adults With Thalassemia Anaemia Gets Approval, Experts Hail It As Game Changer
The US Food and Drug Administrations (FDA) approval of the first-ever oral pill for anaemia in adults with thalassemia marks a historic milestone and can be a game changer in the management of the genetic blood disorder, said
-
Ozempic Maker's Weight Loss Pill Gets Key Clearance In US, Launch Days Away
The US FDA has approved Wegovy pill, the first oral GLP-1 drug for weight loss. With Ozempic already in India, experts say this signals a major shift in obesity care, raising hopes, questions on access, cost and regulation for Indians.
-
Revolutionary New Drug Offers 99.9% Protection Against HIV
The US FDA has approved lenacapavir, a groundbreaking long-acting HIV prevention drug that offers near-complete protection with just two injections per year. Despite its potential, concerns about high costs may limit its global impact.
-
What Is 'Gas Station Heroin'? US Alarmed Over Surge In Its Use And Health Risks
Last month, the FDA issued a formal warning, calling tianeptine a dangerous and growing health trend".
-
FDA Approves 3 Food Colours - And They Are All Natural
This shift comes as part of U.S. health officials' broader health initiative, which includes the "Make America Healthy Again" campaign.
-
Could Dogs Live Longer? Breakthrough Pill Receives Key Regulator Approval
FDA could allow the drug into the market, as soon as next year, once Loyalhits certain safety and manufacturing milestones.
-
FDA Approves Suzetrigine, First Non-Opioid Painkiller in Decades
The FDA has approved suzetrigine, a groundbreaking painkiller that blocks sodium channels to provide opioid-level pain relief without the risks of addiction, sedation, or overdose. Known as Journavx, this drug is the first in over two decades to introduce a new pain relief mechanism. Clinical trials showed it matched opioids in effectiveness but wi...
-
Higher-Dose Wegovy Gets US Nod, Trials Show Over 20% Average Weight Loss, Says Drugmaker
Novo Nordisk said it plans to launch the new formulation, (semaglutide 7.2 mg), in the United States in April 2026.
-
Woman With Stage-3 Colorectal Cancer Recovers In Only 4 Months, Thanks To This New Therapy
Mrinali Dhembla, 27, diagnosed with stage-3 colorectal cancer and Lynch syndrome, recovers rapidly after receiving a dual immunotherapy regimen.
-
Hyderabad-Based Pharmaceutical Gets US Nod For Generic ADHD Drug: Why This Matters And What It Means
ADHD is a neurodevelopmental condition that affects both children and adults. It is characterised by symptoms such as difficulty concentrating, impulsive behaviour and hyperactivity.
-
First Oral Pill For Adults With Thalassemia Anaemia Gets Approval, Experts Hail It As Game Changer
The US Food and Drug Administrations (FDA) approval of the first-ever oral pill for anaemia in adults with thalassemia marks a historic milestone and can be a game changer in the management of the genetic blood disorder, said
-
Ozempic Maker's Weight Loss Pill Gets Key Clearance In US, Launch Days Away
The US FDA has approved Wegovy pill, the first oral GLP-1 drug for weight loss. With Ozempic already in India, experts say this signals a major shift in obesity care, raising hopes, questions on access, cost and regulation for Indians.
-
Revolutionary New Drug Offers 99.9% Protection Against HIV
The US FDA has approved lenacapavir, a groundbreaking long-acting HIV prevention drug that offers near-complete protection with just two injections per year. Despite its potential, concerns about high costs may limit its global impact.
-
What Is 'Gas Station Heroin'? US Alarmed Over Surge In Its Use And Health Risks
Last month, the FDA issued a formal warning, calling tianeptine a dangerous and growing health trend".
-
FDA Approves 3 Food Colours - And They Are All Natural
This shift comes as part of U.S. health officials' broader health initiative, which includes the "Make America Healthy Again" campaign.
-
Could Dogs Live Longer? Breakthrough Pill Receives Key Regulator Approval
FDA could allow the drug into the market, as soon as next year, once Loyalhits certain safety and manufacturing milestones.
-
FDA Approves Suzetrigine, First Non-Opioid Painkiller in Decades
The FDA has approved suzetrigine, a groundbreaking painkiller that blocks sodium channels to provide opioid-level pain relief without the risks of addiction, sedation, or overdose. Known as Journavx, this drug is the first in over two decades to introduce a new pain relief mechanism. Clinical trials showed it matched opioids in effectiveness but wi...
